Affordable Access

deepdyve-link
Publisher Website

France removes hepatitis C treatment prescriber restrictions-But what is the impact of the delay for key populations?

Authors
  • Marcellin, Fabienne1, 2
  • Roux, Perrine1, 2
  • Lazarus, Jeffrey V3
  • Rolland, Benjamin4
  • Carrieri, Patrizia1, 2
  • 1 Aix Marseille Univ, INSERM, IRD, SESSTIM, Sciences Économiques & Sociales de la Santé & Traitement de l'Information Médicale, Marseille, France. , (France)
  • 2 ORS PACA, Observatoire régional de la santé Provence-Alpes-Côte d'Azur, Marseille, France. , (France)
  • 3 Barcelona Institute for Global Health (ISGlobal), Hospital Clínic, University of Barcelona, Barcelona, Spain. , (Spain)
  • 4 Service Universitaire d'Addictologie de Lyon (SUAL), CH Le Vinatier, Université de Lyon, UCBL, Bron, France. , (France)
Type
Published Article
Journal
Liver international : official journal of the International Association for the Study of the Liver
Publication Date
Dec 01, 2019
Volume
39
Issue
12
Pages
2418–2419
Identifiers
DOI: 10.1111/liv.14208
PMID: 31436366
Source
Medline
Keywords
Language
English
License
Unknown
Report this publication

Statistics

Seen <100 times